HypOrth

Partner 7 - Mathys Ltd Bettlach

Daniel Delfosse

   Mathys Ltd Bettlach

Dr.  Daniel Delfosse

Phone: +41 32 644 1586

E-Mail


Mathys Ltd Bettlach

Robert Mathys Street 5

2544 Bettlach

Switzerland

Website

Project Team

Viola Mai, MSc

Innovation Manager, Innovation Group

E-Mail

Dr. Reto Lerf

Head of Polymer Development

E-Mail

Thomas  Oberbach

Head of Ceramic R&D

E-Mail

Company presentation

Since 1946, Mathys has been developing, producing and distributing products for the artificial joint replacement (hip, knee, shoulder, finger) as well as synthetic bone graft substitutes. Mathys today has 470 employees and a turnover of 118 mio CHF.
Mathys is the only orthopaedic company in the world that manufactures its polymer and ceramic materials in-house. The Innovation & Technology department, located in Bettlach, Switzerland and Mörsdorf; Germany, consists of a dozen scientific personnel whose sole task is to solve well defined clinical problems with a novel approach, using the most advanced material and design options available. Mathys is therefore perfectly placed to develop, manufacture and disseminate innovative implants made of novel materials.
The successful marketing of a novel implant is not possible without a number of labour-intensive steps, such as biocompatibility assessment and biomechanical bench testing, development of instruments for easy and accurate placement of the implants, registration of products for CE-marking, education of surgeons, clinical documentation and post-marketing surveillance. For Mathys, the introduction of new implants is a standardised process. Mathys has its own concepts of training and marketing. Additionally, Mathys has developed far reaching advertising strategies, e.g. its own journal “Move” reaches more than 18.000 orthopaedic surgeons world-wide 6 times per year.

All key persons and staff members at Mathys who will be undertaking the work all have at least 10 years of experience dealing with orthopaedic materials and implants. The listed scientific personnel (see below) has developed, registered and introduced two new ceramic materials, one new polymer and two new coatings for orthopaedic implants in the last 6 years. As one example, vitamys – a vitamin-doped, highly cross-linked polyethylene – was first implanted in 2009. Within 3 years, it has already reached a turnover of >10 mio CHF and has become a cornerstone for the hip marketing at Mathys.

Mathys is leading WP10 and is involved in WP08. Its main contributions are the selection of the best material/coating combination, the manufacturing technology and benchmark testing for hip, knee and shoulder endoprostheses, and finally the registration, marketing and dissemination of implants.

 

 

HypOrth Consortium

HypOrth Consortium

Quicklinks

Home
Menu
Search
Top

Newsletter Subscription

News Section

Public poster session on September 1. Read more

Social Media

Twitter Google Plus Facebook
Home
Menu
Search
Top